CannabisNewsBreaks

TuesdayMar 08, 2022 12:22 pm

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Approval from Health Canada Recognizing RYAH Smart Medical Inhaler System as Medical Device

RYAH Group (CSE: RYAH) today announced that its subsidiary, RYAH Medtech Inc., has received a Health Canada Medical Device License (“MDL”) for its proprietary Internet of Things (“IoT”) powered medical cannabis inhaler, proprietary cartridges and software application associated with the device (the “RYAH Smart Medical Inhaler System”). According to the update, Health Canada License number 107475 allows RYAH to market its Smart Medical Inhaler System to medical patients in Canada and potentially represents a significant boost to RYAH’s growth strategy. “The approval from Health Canada recognizing the RYAH Smart Inhaler System as a medical device is a major step towards…

Continue Reading

FridayMar 04, 2022 2:15 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) On Path Toward Improved Margins Through Vertical Integration

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a cannabis and CBD product brand builder with a presence in California, Arizona, Oklahoma, Illinois, Michigan, and Florida, most recently celebrated the news that Michigan had granted it adult recreational use prequalification status for manufacture, followed by full licensing to make both medical and adult-use cannabis products in the state. “The company’s lease assignment for a 15,000-square-foot manufacturing and processing facility in the city of Warren led to the launch of operations there [in January], with ‘all necessary equipment already installed and inspections completed’ for medical and adult-use products,” a recent…

Continue Reading

FridayMar 04, 2022 11:08 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Completes 1st US Import of CBD Products from Colombia

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced that it has completed its first import of CBD-containing food and beverage products into the United States from Colombia under its Mambe brand. The move comes after Colombian President Ivan Duque signed Resolution 227 last week, providing the necessary framework for the use, distribution and export of cannabis, dried flower and other non-psychoactive derivatives. “We are thrilled to be the first Colombian cannabis operator to capitalize on the law change President Duque signed into effect,” said Flora Growth CEO Luis Merchan. “We are…

Continue Reading

ThursdayMar 03, 2022 3:02 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Portfolio, Presence in Growing Rare Cannabinoid Market

InMed Pharmaceuticals (NASDAQ: INM) is uniquely positioned to leverage the growing worldwide awareness of the potential of cannabinoids and the rising demand for rare cannabinoids. The company has begun this year on a high, following the 2021 acquisition of BayMedica and the launch of cannabicitran (“CBT”) sales. “With the launch of business-to-business sales of CBT in the health and wellness sector, InMed has further expanded its portfolio and its presence in the growing rare cannabinoid market,” reports a recent article. “CBT is the first of several new products InMed is planning to launch in the first half of 2022 in…

Continue Reading

ThursdayMar 03, 2022 2:44 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Demonstrates Faster, Higher Overall Delivery of Sildenafil into Bloodstream

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently released positive results from an animal study that evaluated DehydraTECH(TM) processing of the phosphodiesterase inhibitor (“PDE5 inhibitor”) sildenafil as potential use in the management of erectile dysfunction. “A clear trend emerged during the course of the study – a faster and higher overall delivery of sildenafil into the bloodstream. During the animal study, it was determined that in as little as four minutes of dosing, the DehydraTECH formulation of sildenafil delivered 74% more of the PDE5 inhibitor into the bloodstream on average than the concentration-matched, generic control formulation. Within seven minutes, the DehydraTECH-sildenafil formulation…

Continue Reading

ThursdayMar 03, 2022 1:52 pm

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) on Track to Secure Approval of Hourglass(TM) NNCP

Grapefruit USA (OTCQB: GPFT), an innovative California-based cannabiotech company, today provided an update on progress with its previously announced Notice of New Cannabis Product (“NNCP”) filed with Health Canada for its patented Hourglass(TM) Time Release THC+CBD infused Topical Delivery Cream. Health Canada is the department of the federal government responsible for national health policy, and its approval of the NNCP will enable Grapefruit to sell its patented Hourglass to licensed retail outlets throughout Canada. According to the update, on Feb. 18, 2022, Grapefruit received an inquiry from Health Canada about the composition of specific Hourglass ingredients. Grapefruit’s timely response was…

Continue Reading

WednesdayMar 02, 2022 11:28 am

CannabisNewsBreaks – Flora Growth Corp.’s (NASDAQ: FLGC) Vessel Enters Distribution Agreement with JustCBD Partner

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has inked a distribution deal with Florida-based Speedy Distribution. Speedy is a core partner of JustCBD, which was just acquired by Flora Growth in a transaction announced earlier this week. The announcement noted that its consumer technology brand, Vessel, will launch in Speedy’s cash-and-carry distribution center and will include a select offering from FLGC’s product portfolio; the products will expand into traditional smokeshop channels. JustCBD has more than 300 products and some 300,000 customers, with a network of more than 14,000 stores across the…

Continue Reading

MondayFeb 28, 2022 2:50 pm

CannabisNewsBreaks – American Cannabis Partners Standing Distinct Thanks to Sustainable Practices, Strategic Positioning

American Cannabis Partners (“ACP”), a Jamaican experience canna-business innovator, is committed to doing its part as the sustainability trend permeates all sectors, including cannabis. Sustainability is a growing priority for businesses in today’s environment-conscious and energy-aware world. A recent article notes that the advantages of sustainability are twofold: making a positive impact on the environment and connecting with consumers who are becoming increasingly aware and supportive of companies working to make a difference. “ACP follows an organic cultivation model that includes implementing sustainable operating practices designed to reduce the company’s environmental footprint and increase its social responsibility,” the article reads.…

Continue Reading

MondayFeb 28, 2022 1:15 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Strengthens Foothold in US Wellness Market with Acquisition of JustCBD

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced that it has acquired 100% of the equity interests in each of Just Brands LLC and High Roller Private Label LLC for cash consideration of US$16.0 million and 9.5 million privately issued Flora common shares, subject to certain potential future adjustments. According to the update, Just Brands and High Roller are the owners of the JustCBD brand and associated operations (collectively “JustCBD”). “We are thrilled to announce this news today and welcome the JustCBD team to Flora. To build such a recognizable brand…

Continue Reading

FridayFeb 25, 2022 1:35 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Optimistic of Positive Study Results, Eyes ‘Most Exciting Year Ever’

Lexaria Bioscience Corp. (NASDAQ: LEXX) achieved myriad milestones in 2021, with CEO Chris Bunka noting in an annual letter to shareholders that January 2021 marked the birth of a modern version of the company. A recent article contains excerpts from the letter, in which Bunka writes, “During 2021, we completed research & development (‘R&D’) and validating work equal to or greater than all the combined amount previously completed since 2018! We have conducted studies across broad areas of interest but also concentrated in specific areas where we have supportive data,” In 2021, Lexaria’s most significant area of investigation was DehydraTECH(TM)-processed…

Continue Reading